BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29658093)

  • 21. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
    Yang J; Liu P; Tian M; Li Y; Chen W; Li X
    Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer.
    Kim K; Taylor SL; Ganti S; Guo L; Osier MV; Weiss RH
    OMICS; 2011 May; 15(5):293-303. PubMed ID: 21348635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic evaluation of urine from renal cell carcinoma using SELDI-TOF-MS and tree analysis pattern.
    Wu DL; Zhang WH; Wang WJ; Jing SB; Xu YM
    Technol Cancer Res Treat; 2008 Jun; 7(3):155-60. PubMed ID: 18473487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
    Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
    J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of quantitative shotgun proteomics to identify fibronectin 1 as a potential plasma biomarker for clear cell carcinoma of the kidney.
    Yokomizo A; Takakura M; Kanai Y; Sakuma T; Matsubara J; Honda K; Naito S; Yamada T; Ono M
    Cancer Biomark; 2011-2012; 10(3-4):175-83. PubMed ID: 22674303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Metabolomic and Lipidomic Profiling of Human Kidney Tissue: A Platform Comparison.
    Leuthold P; Schaeffeler E; Winter S; Büttner F; Hofmann U; Mürdter TE; Rausch S; Sonntag D; Wahrheit J; Fend F; Hennenlotter J; Bedke J; Schwab M; Haag M
    J Proteome Res; 2017 Feb; 16(2):933-944. PubMed ID: 27992229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
    Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
    Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis.
    Ganti S; Taylor SL; Abu Aboud O; Yang J; Evans C; Osier MV; Alexander DC; Kim K; Weiss RH
    Cancer Res; 2012 Jul; 72(14):3471-9. PubMed ID: 22628425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC.
    Szabó Z; Szegedi K; Gombos K; Mahua C; Flaskó T; Harda K; Halmos G
    Urol Oncol; 2016 Dec; 34(12):533.e21-533.e27. PubMed ID: 27427222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ambient ionization mass spectrometric analysis of human surgical specimens to distinguish renal cell carcinoma from healthy renal tissue.
    Alfaro CM; Jarmusch AK; Pirro V; Kerian KS; Masterson TA; Cheng L; Cooks RG
    Anal Bioanal Chem; 2016 Aug; 408(20):5407-14. PubMed ID: 27206411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive urinary metabolomic approach for identifying kidney cancerr.
    Kind T; Tolstikov V; Fiehn O; Weiss RH
    Anal Biochem; 2007 Apr; 363(2):185-95. PubMed ID: 17316536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis A virus cellular receptor 1/kidney injury molecule-1 is a susceptibility gene for clear cell renal cell carcinoma and hepatitis A virus cellular receptor/kidney injury molecule-1 ectodomain shedding a predictive biomarker of tumour progression.
    Cuadros T; Trilla E; Vilà MR; de Torres I; Vilardell J; Messaoud NB; Salcedo M; Sarró E; López-Hellin J; Blanco A; Mir C; Ramón y Cajal S; Itarte E; Morote J; Meseguer A
    Eur J Cancer; 2013 May; 49(8):2034-47. PubMed ID: 23352434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.
    White NM; Masui O; Desouza LV; Krakovska O; Metias S; Romaschin AD; Honey RJ; Stewart R; Pace K; Lee J; Jewett MA; Bjarnason GA; Siu KW; Yousef GM
    Oncotarget; 2014 Jan; 5(2):506-18. PubMed ID: 24504108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
    Zhang L; Jiang H; Xu G; Chu N; Xu N; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y; Wang L
    Biosci Trends; 2016 Jul; 10(3):210-9. PubMed ID: 27319973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma.
    Li G; Zhao A; Péoch M; Cottier M; Mottet N
    Urol Oncol; 2017 May; 35(5):294-299. PubMed ID: 28089386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathway analysis of kidney cancer using proteomics and metabolic profiling.
    Perroud B; Lee J; Valkova N; Dhirapong A; Lin PY; Fiehn O; Kültz D; Weiss RH
    Mol Cancer; 2006 Nov; 5():64. PubMed ID: 17123452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Prognostic Biomarkers in the Urinary Peptidome of the Small Renal Mass.
    Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
    Am J Pathol; 2019 Dec; 189(12):2366-2376. PubMed ID: 31761032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
    Lou N; Ruan AM; Qiu B; Bao L; Xu YC; Zhao Y; Sun RL; Zhang ST; Xu GH; Ruan HL; Yuan CF; Han WW; Shi HC; Yang HM; Zhang XP
    Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ARCHITECT® urine-neutrophil gelatinase-associated lipocalin (u-NGAL) assay as new prognostic marker for clear cell Renal Cell Carcinoma (ccRCC) (preliminary results).
    Ben Khadhra H; Rose-Robert F; Herpe YE; Sevestre H; Choukroun G; Catherine L; Amant C; Saint F
    Int Urol Nephrol; 2021 Jan; 53(1):59-67. PubMed ID: 32783115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles.
    Grützmann K; Salomo K; Krüger A; Lohse-Fischer A; Erdmann K; Seifert M; Baretton G; Aust D; William D; Schröck E; Thomas C; Füssel S
    Biol Direct; 2024 May; 19(1):38. PubMed ID: 38741178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.